Ann: Medibio Quarterly Update and Cashflow Report, page-63

Good thing is that there are virtually no willing sellers here. We have met Claude and team and very impressed with how things are developing here. - the last Ann a good start of the commercial push. Health biometrics aka MEB, PCK, RSH is the new direction in mobile health monitoring. The "Big data" side of these businesses is massive in value as well as the utility for people/doctors to monitor their bodies and take action re health threat prevention.

MEB market cap a steal when compared to others in this space - good team behind them and new investors on board. Can see another junior Paincheck in the making.....